The Best Molecular Biomarkers Available for Informing Immunotherapy of Cancer

David Spigel, MD

Video Categories: 2018 ASCO Insights, Biomarkers, and Video Library

Dr David Spigel talks about currently available and emerging biomarkers that predict the greatest sensitivity to immunotherapy, including his insight into PD-L1, MSI, and TMB.

September 2, 2015

Takeda Oncology Resources for Meeting the Challenges with Oncolytics

Dixie-Lee Esseltine, MD and George Mulligan, PhD describe how Takeda Oncology is working to provide resources that assist patients in understanding their disease and their goals of treatment

July 25, 2018

The Greatest Challenges in Incorporating Biomarkers into Cancer Care

Dr David Spigel discusses challenges and solutions to incorporating cancer biomarkers into patient care, including finding pathology resources to do the testing, issues around reimbursement, and educating colleagues on the value and operational aspects of biomarker testing in delivering personalized therapy to patients with cancer.